These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26355760)
21. Pharmacogenetic versus clinical dosing of warfarin in individuals of Chinese and African-American ancestry: assessment using data simulation. Syn NL; Lee SC; Brunham LR; Goh BC Pharmacogenet Genomics; 2015 Oct; 25(10):491-500. PubMed ID: 26230382 [TBL] [Abstract][Full Text] [Related]
22. The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen. Sconce EA; Khan TI; Wynne HA; Avery P; Monkhouse L; King BP; Wood P; Kesteven P; Daly AK; Kamali F Blood; 2005 Oct; 106(7):2329-33. PubMed ID: 15947090 [TBL] [Abstract][Full Text] [Related]
23. Implementing Algorithm-Guided Warfarin Dosing in an Ethnically Diverse Patient Population Using Electronic Health Records and Preemptive CYP2C9 and VKORC1 Genetic Testing. Obeng AO; Kaszemacher T; Abul-Husn NS; Gottesman O; Vega A; Waite E; Myers K; Cho J; Bottinger EP; Ellis SB; Scott SA Clin Pharmacol Ther; 2016 Nov; 100(5):427-430. PubMed ID: 27393744 [TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients. Perini JA; Struchiner CJ; Silva-Assunção E; Santana IS; Rangel F; Ojopi EB; Dias-Neto E; Suarez-Kurtz G Clin Pharmacol Ther; 2008 Dec; 84(6):722-8. PubMed ID: 18754001 [TBL] [Abstract][Full Text] [Related]
25. Pharmacogenetics of warfarin dosing in patients of African and European ancestry. Shendre A; Dillon C; Limdi NA Pharmacogenomics; 2018 Nov; 19(17):1357-1371. PubMed ID: 30345882 [TBL] [Abstract][Full Text] [Related]
26. Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9. Sagreiya H; Berube C; Wen A; Ramakrishnan R; Mir A; Hamilton A; Altman RB Pharmacogenet Genomics; 2010 Jul; 20(7):407-13. PubMed ID: 20442691 [TBL] [Abstract][Full Text] [Related]
27. Estimation of the warfarin dose with a pharmacogenetic refinement algorithm in Chinese patients mainly under low-intensity warfarin anticoagulation. Xu Q; Xu B; Zhang Y; Yang J; Gao L; Zhang Y; Wang H; Lu C; Zhao Y; Yin T Thromb Haemost; 2012 Dec; 108(6):1132-40. PubMed ID: 23015069 [TBL] [Abstract][Full Text] [Related]
28. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration. Santos PC; Marcatto LR; Duarte NE; Gadi Soares RA; Cassaro Strunz CM; Scanavacca M; Krieger JE; Pereira AC Pharmacogenomics; 2015 Jul; 16(8):865-76. PubMed ID: 26050796 [TBL] [Abstract][Full Text] [Related]
29. Validation and comparison of pharmacogenetics-based warfarin dosing algorithms for application of pharmacogenetic testing. Roper N; Storer B; Bona R; Fang M J Mol Diagn; 2010 May; 12(3):283-91. PubMed ID: 20228265 [TBL] [Abstract][Full Text] [Related]
30. Warfarin dosing algorithm using clinical, demographic and pharmacogenetic data from Chinese patients. You JH; Wong RS; Waye MM; Mu Y; Lim CK; Choi KC; Cheng G J Thromb Thrombolysis; 2011 Jan; 31(1):113-8. PubMed ID: 20585834 [TBL] [Abstract][Full Text] [Related]
31. VKORC1 and CYP2C9 genotypic data-based dose prediction alone does not accurately predict warfarin dose requirements in some Malaysian patients. Chua YA; Abdullah WZ; Yusof Z; Gan SH Turk J Med Sci; 2015; 45(4):913-8. PubMed ID: 26422867 [TBL] [Abstract][Full Text] [Related]
33. Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. Gage BF; Eby C; Milligan PE; Banet GA; Duncan JR; McLeod HL Thromb Haemost; 2004 Jan; 91(1):87-94. PubMed ID: 14691573 [TBL] [Abstract][Full Text] [Related]
34. Development and comparison of a new personalized warfarin stable dose prediction algorithm in Chinese patients undergoing heart valve replacement. Tan SL; Li Z; Song GB; Liu LM; Zhang W; Peng J; Zhang T; Jia FF; Zhou G; Zhou HH; Zhou XM Pharmazie; 2012 Nov; 67(11):930-7. PubMed ID: 23210243 [TBL] [Abstract][Full Text] [Related]
35. New genetic variant that might improve warfarin dose prediction in African Americans. Schelleman H; Brensinger CM; Chen J; Finkelman BS; Rieder MJ; Kimmel SE Br J Clin Pharmacol; 2010 Sep; 70(3):393-9. PubMed ID: 20716240 [TBL] [Abstract][Full Text] [Related]
37. Comparison of Nine Statistical Model Based Warfarin Pharmacogenetic Dosing Algorithms Using the Racially Diverse International Warfarin Pharmacogenetic Consortium Cohort Database. Liu R; Li X; Zhang W; Zhou HH PLoS One; 2015; 10(8):e0135784. PubMed ID: 26305568 [TBL] [Abstract][Full Text] [Related]
38. VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study. Zambon CF; Pengo V; Padrini R; Basso D; Schiavon S; Fogar P; Nisi A; Frigo AC; Moz S; Pelloso M; Plebani M Pharmacogenomics; 2011 Jan; 12(1):15-25. PubMed ID: 21174619 [TBL] [Abstract][Full Text] [Related]
39. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation. Anderson JL; Horne BD; Stevens SM; Grove AS; Barton S; Nicholas ZP; Kahn SF; May HT; Samuelson KM; Muhlestein JB; Carlquist JF; Circulation; 2007 Nov; 116(22):2563-70. PubMed ID: 17989110 [TBL] [Abstract][Full Text] [Related]
40. A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms. Cini M; Legnani C; Cosmi B; Guazzaloca G; Valdrè L; Frascaro M; Palareti G Eur J Clin Pharmacol; 2012 Aug; 68(8):1167-74. PubMed ID: 22349464 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]